Magazine
Issue 4-2019
Letter from the Editor
Magnus Gisslén
Weight gain in Basel
Graeme Moyle
Satellite symposium at NSCMID
The plan to eliminate hepatitis C
Helena Nordlund
EACS Guidelines 10.0:
what is new for ART?
José R Arribas
Hepatitis News from
The Liver Meeting in Boston
Johannes Vermehren
HIV & Hepatitis Nordic Conference 2019
Per Lundblad
Abstracts selected for presentation at the
HIV & Hepatitis Nordic Conference
Per Lundblad
Hepatitis at the HIV & Hepatitis Nordic Conference
Per Lundblad
Satellite symposiums at the
HIV & Hepatitis Nordic Conference
Per Lundblad
Notes 2019
Leo Flamholc
Topical Conferences 2020
Issue 3-2019
Letter from the Editor
Magnus Gisslén
Are women with well-treated HIV still at higher
risk of developing cervical cancer?
An update on HPV related cervical disease in women living with HIV
Christina Carlander
Weight Gain Redux: More from Mexico
Graeme Moyle
Surveillance of patients who have achieved a
sustained virologic response after treatment
for hepatitis C: the more the better?
Johannes Vermehren
Trials of Initial ART at IAS 2019: Weighting the Data
José R Arribas
Hepatitis at the ILC 2019
Per Lundblad
Increasing diversity and population reach
Per Lundblad
Test, simplify treatment and cure
Per Lundblad
Notes 2019
Leo Flamholc
Topical Conferences 2019
Issue 2-2019
Letter from the Editor
Magnus Gisslén
Two Pieces
Graeme Moyle
The biological clock of persons living with HIV:
is it running fast?
José R Arribas
CROI 2019
Per Lundblad
Hepatitis B News from the International
Liver Congress in Vienna 2019
Johannes Vermehren
Notes 2019
Leo Flamholc
Topical Conferences 2019
Issue 1-2019
Letter from the Editor
Magnus Gisslén
HIV Glasgow 2018
Per Lundblad
Long acting CROI
José R Arribas
Weight gain in people on ART:
syndrome or secular trend?
Graeme Moyle
Update on the management of
chronic hepatitis B in pregnancy
Johannes Vermehren
Notes 2019
Leo Flamholc
Topical Conferences 2019
Issue 4-2018
Letter from the Editor
Magnus Gisslén
Dual ART: new studies presented at HIV Glasgow 2018
José R Arribas
Is ART in need of an injection
Graeme Moyle
Hepatitis C News from The Liver Meeting in San Francisco
Johannes Vermehren
HIV & Hepatitis Nordic conference
Per Lundblad
Hepatitis at HIV & Hepatitis Nordic conference
Per Lundblad
Satellite symposiums at HIV & Hepatitis Nordic conference
Per Lundblad
Notes 2018
Leo Flamholc
Topical Conferences 2019
Issue 3-2018
Letter from the Editor
Magnus Gisslén
Gemini Trials: the end of triplets?
José R Arribas
BHIVA -events
Rageshri Dhairyawan
Dolutegravir at conception
Graeme Moyle
Management of hepatitis E virus infection -a summary of the new EASL Clinical Practice Guidelines
Johannes Vermehren
Notes 2018
Leo Flamholc
Topical Conferences 2018-2019
Issue 2-2018
Letter from the Editor
Magnus Gisslén
Hepatitis at the ILC
Per Lundblad
Satellite symposiums at the European ILC
Per Lundblad
BHIVA – events
Rageshri Dhairyawan
What’s new in hepatitis? A report from the International Liver Congress in Paris
Johannes Vermehren
Archived nucleos(t)ide resistance mutations in the era of high genetic barrier antiretrovirals: still matter?
José R Arribas
The new drugs in later lines of therapy
Graeme Moyle
Notes 2018
Leo Flamholc
Issue 1-2018
Letter from the Editor
Magnus Gisslén
CROI in Boston 2018
Per Lundblad
European AIDS Conference 2017
Per Lundblad
BHIVA – resent events
Rageshri Dhairyawan
Satellite symposiums at the European AIDS Congress
Per Lundblad
The EASL 2017 Clinical Practice Guidelineson HBV infection
Johannes Vermehren
The thin harvest of studies of antiretroviral therapy in naïve
José R Arribas
The bad old days
Graeme Moyle
Notes 2018
Leo Flamholc